Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Oral health status and possible explanatory factors of an inner-city low-income community.

Hau KP, Currie BL, Ng SP, Le N, Poh CF.

J Dent Sci. 2017 Mar;12(1):49-55. doi: 10.1016/j.jds.2016.06.008. Epub 2016 Nov 11.

PMID:
30895023
2.

Plasma-Derived Inflammatory Proteins Predict Oral Squamous Cell Carcinoma.

Liu KYP, Lu XJD, Zhu YS, Le N, Kim H, Poh CF.

Front Oncol. 2018 Dec 4;8:585. doi: 10.3389/fonc.2018.00585. eCollection 2018.

3.

Using ddPCR to assess the DNA yield of FFPE samples.

Lu XJD, Liu KYP, Zhu YS, Cui C, Poh CF.

Biomol Detect Quantif. 2018 Nov 7;16:5-11. doi: 10.1016/j.bdq.2018.10.001. eCollection 2018 Dec.

4.

Potential clinical implications of HPV status and expressions of p53 and cyclin D1 among oropharyngeal cancer patients.

Lu XJD, Liu KYP, Soares RC, Thomson T, Prisman E, Wu J, Poh CF.

J Oral Pathol Med. 2018 Nov;47(10):945-953. doi: 10.1111/jop.12779. Epub 2018 Sep 27.

PMID:
30191616
5.

Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications.

Nikitakis NG, Pentenero M, Georgaki M, Poh CF, Peterson DE, Edwards P, Lingen M, Sauk JJ.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):650-669. doi: 10.1016/j.oooo.2018.03.012. Epub 2018 Apr 4. Review.

PMID:
29709496
6.

Altered Immune-Related Gene Expressions Indicate Oral Cancer Nodal Disease.

Liu KYP, Lu XJD, Zhu Y, Yip S, Poh CF.

J Dent Res. 2018 Jun;97(6):709-716. doi: 10.1177/0022034518758045. Epub 2018 Feb 28.

PMID:
29489424
7.

Using quantitative tissue phenotype to assess the margins of surgical samples from a pan-Canadian surgery study.

Guillaud M, MacAulay CE, Berean KW, Bullock M, Guggisberg K, Klieb H, Puttagunta L, Penner C, Kwan K, Rosin MP, Poh CF.

Head Neck. 2018 Jun;40(6):1263-1270. doi: 10.1002/hed.25106. Epub 2018 Feb 16.

PMID:
29451953
8.

An actionable test using loss of heterozygosity in identifying high-risk oral premalignant lesions.

Liu KYP, Lu XJD, Cheng YL, Klieb H, Ng S, McNeil K, Karsan A, Poh CF.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Dec 18. pii: S2212-4403(17)31208-7. doi: 10.1016/j.oooo.2017.10.019. [Epub ahead of print]

PMID:
29428696
9.

Tumor-associated immune aggregates in oral cancer: Their cellular composition and potential prognostic significance.

de Sousa Lopes MLD, Liu Y, Liu KY, da Silveira √ČJD, Poh CF.

Med Hypotheses. 2017 Oct;108:17-23. doi: 10.1016/j.mehy.2017.07.017. Epub 2017 Jul 16.

PMID:
29055393
10.

Detection of clinically relevant copy number alterations in oral cancer progression using multiplexed droplet digital PCR.

Hughesman CB, Lu XJD, Liu KYP, Zhu Y, Towle RM, Haynes C, Poh CF.

Sci Rep. 2017 Sep 19;7(1):11855. doi: 10.1038/s41598-017-11201-4.

11.

Dual-mode endomicroscopy for detection of epithelial dysplasia in the mouth: a descriptive pilot study.

Bodenschatz N, Poh CF, Lam S, Lane P, Guillaud M, MacAulay CE.

J Biomed Opt. 2017 Aug;22(8):1-10. doi: 10.1117/1.JBO.22.8.086005.

PMID:
28823113
12.

Improving public awareness and outcomes for oral cancer.

Poh CF.

Future Sci OA. 2016 Feb 11;2(1):FSO103. doi: 10.4155/fsoa-2016-0004. eCollection 2016 Mar.

13.

Prospects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant Lesions.

Saini R, Lee NV, Liu KY, Poh CF.

Cancers (Basel). 2016 Sep 2;8(9). pii: E83. doi: 10.3390/cancers8090083. Review.

14.

Nodal Disease Burden for Early-Stage Oral Cancer.

Liu KY, Durham JS, Wu J, Anderson DW, Prisman E, Poh CF.

JAMA Otolaryngol Head Neck Surg. 2016 Nov 1;142(11):1111-1119. doi: 10.1001/jamaoto.2016.2241.

PMID:
27560665
15.

A Robust Protocol for Using Multiplexed Droplet Digital PCR to Quantify Somatic Copy Number Alterations in Clinical Tissue Specimens.

Hughesman CB, Lu XJ, Liu KY, Zhu Y, Poh CF, Haynes C.

PLoS One. 2016 Aug 18;11(8):e0161274. doi: 10.1371/journal.pone.0161274. eCollection 2016.

16.

Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, Canada.

Cromwell I, Regier DA, Peacock SJ, Poh CF.

Oncologist. 2016 Sep;21(9):1099-106. doi: 10.1634/theoncologist.2015-0433. Epub 2016 Jul 11.

17.

Fluorescence Visualization-Guided Surgery for Early-Stage Oral Cancer.

Poh CF, Anderson DW, Durham JS, Chen J, Berean KW, MacAulay CE, Rosin MP.

JAMA Otolaryngol Head Neck Surg. 2016 Mar;142(3):209-16. doi: 10.1001/jamaoto.2015.3211.

PMID:
26769431
18.

Recurring DNA copy number gain at chromosome 9p13 plays a role in the activation of multiple candidate oncogenes in progressing oral premalignant lesions.

Towle R, Tsui IF, Zhu Y, MacLellan S, Poh CF, Garnis C.

Cancer Med. 2014 Oct;3(5):1170-84. doi: 10.1002/cam4.307. Epub 2014 Jul 24.

19.

Oral mucosa optical biopsy by a novel handheld fluorescent confocal microscope specifically developed: technologic improvements and future prospects.

Contaldo M, Poh CF, Guillaud M, Lucchese A, Rullo R, Lam S, Serpico R, MacAulay CE, Lane PM.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Dec;116(6):752-8. doi: 10.1016/j.oooo.2013.09.006.

PMID:
24237726
20.

Photodynamic therapy: a review and its prospective role in the management of oral potentially malignant disorders.

Saini R, Poh CF.

Oral Dis. 2013 Jul;19(5):440-51. doi: 10.1111/odi.12003. Review.

PMID:
24079944
21.

Global analysis of DNA methylation changes during progression of oral cancer.

Towle R, Truong D, Hogg K, Robinson WP, Poh CF, Garnis C.

Oral Oncol. 2013 Nov;49(11):1033-42. doi: 10.1016/j.oraloncology.2013.08.005. Epub 2013 Sep 13.

PMID:
24035722
22.

Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer.

Lin RJ, Lubpairee T, Liu KY, Anderson DW, Durham S, Poh CF.

J Otolaryngol Head Neck Surg. 2013 Mar 19;42:23. doi: 10.1186/1916-0216-42-23.

23.

Ex vivo confocal imaging with contrast agents for the detection of oral potentially malignant lesions.

El Hallani S, Poh CF, Macaulay CE, Follen M, Guillaud M, Lane P.

Oral Oncol. 2013 Jun;49(6):582-90. doi: 10.1016/j.oraloncology.2013.01.009. Epub 2013 Feb 12.

24.

Differential expression of miRNAs in the serum of patients with high-risk oral lesions.

Maclellan SA, Lawson J, Baik J, Guillaud M, Poh CF, Garnis C.

Cancer Med. 2012 Oct;1(2):268-74. doi: 10.1002/cam4.17. Epub 2012 Jul 19.

25.

High throughput image cytometry for detection of suspicious lesions in the oral cavity.

Macaulay C, Poh CF, Guillaud M, Michele Williams P, Laronde DM, Zhang L, Rosin MP.

J Biomed Opt. 2012 Aug;17(8):086004-1. doi: 10.1117/1.JBO.17.8.086004.

PMID:
23224191
26.

Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer.

Zhang L, Poh CF, Williams M, Laronde DM, Berean K, Gardner PJ, Jiang H, Wu L, Lee JJ, Rosin MP.

Cancer Prev Res (Phila). 2012 Sep;5(9):1081-9. doi: 10.1158/1940-6207.CAPR-12-0173. Epub 2012 Aug 21.

27.

MicroRNAs in an oral cancer context - from basic biology to clinical utility.

Gorenchtein M, Poh CF, Saini R, Garnis C.

J Dent Res. 2012 May;91(5):440-6. doi: 10.1177/0022034511431261. Epub 2011 Dec 13. Review.

PMID:
22166582
28.

Canadian Optically-guided approach for Oral Lesions Surgical (COOLS) trial: study protocol for a randomized controlled trial.

Poh CF, Durham JS, Brasher PM, Anderson DW, Berean KW, MacAulay CE, Lee JJ, Rosin MP.

BMC Cancer. 2011 Oct 25;11:462. doi: 10.1186/1471-2407-11-462.

29.

Unique FISH patterns associated with cancer progression of oral dysplasia.

Poh CF, Zhu Y, Chen E, Berean KW, Wu L, Zhang L, Rosin MP.

J Dent Res. 2012 Jan;91(1):52-7. doi: 10.1177/0022034511425676. Epub 2011 Oct 11.

30.

Squamous cell carcinoma and precursor lesions: diagnosis and screening in a technical era.

Poh CF, MacAulay CE, Laronde DM, Williams PM, Zhang L, Rosin MP.

Periodontol 2000. 2011 Oct;57(1):73-88. doi: 10.1111/j.1600-0757.2011.00386.x. Review. No abstract available.

31.

How do I evaluate a patient with a swollen lip?

Gu Y, Williams M, Poh CF.

J Can Dent Assoc. 2010;76:a92. No abstract available.

32.

Dentigerous cyst: a retrospective clinicopathological analysis of 2082 dentigerous cysts in British Columbia, Canada.

Zhang LL, Yang R, Zhang L, Li W, MacDonald-Jankowski D, Poh CF.

Int J Oral Maxillofac Surg. 2010 Sep;39(9):878-82. doi: 10.1016/j.ijom.2010.04.048. Epub 2010 Jun 3.

PMID:
20605411
33.

A dynamic oral cancer field: unraveling the underlying biology and its clinical implication.

Tsui IF, Garnis C, Poh CF.

Am J Surg Pathol. 2009 Nov;33(11):1732-8. doi: 10.1097/PAS.0b013e3181b669c2.

34.

Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias.

Tsui IF, Poh CF, Garnis C, Rosin MP, Zhang L, Lam WL.

Int J Cancer. 2009 Nov 1;125(9):2219-28. doi: 10.1002/ijc.24611.

35.

Tracing the "at-risk" oral mucosa field with autofluorescence: steps toward clinical impact.

Poh CF, MacAulay CE, Zhang L, Rosin MP.

Cancer Prev Res (Phila). 2009 May;2(5):401-4. doi: 10.1158/1940-6207.CAPR-09-0060. Epub 2009 Apr 28. Review. No abstract available.

36.

Is the message clear? Talking with your patient about oral cancer screening.

Currie BL, Williams PM, Poh CF.

J Can Dent Assoc. 2008 Apr;74(3):255-6. No abstract available.

PMID:
18389924
37.

Can oral cancer occur in someone without known risk?

Poh CF, Williams PM.

J Can Dent Assoc. 2008 Apr;74(3):253-4. No abstract available.

PMID:
18389923
38.

Biopsy and histopathologic diagnosis of oral premalignant and malignant lesions.

Poh CF, Ng S, Berean KW, Williams PM, Rosin MP, Zhang L.

J Can Dent Assoc. 2008 Apr;74(3):283-8.

39.

Evaluation of a suspicious oral mucosal lesion.

Williams PM, Poh CF, Hovan AJ, Ng S, Rosin MP.

J Can Dent Assoc. 2008 Apr;74(3):275-80.

40.

New hope for an oral cancer solution: together we can make a difference.

Rosin MP, Poh CF, Elwood JM, Williams PM, Gallagher R, MacAulay C, Lam WW, Auluck A, Zhang L, Hislop TG.

J Can Dent Assoc. 2008 Apr;74(3):261-6.

41.

Voices from the community--the voice of an oral cancer patient.

Biggar H, Poh CF, Rosin M, Williams PM.

J Can Dent Assoc. 2008 Apr;74(3):237-8. No abstract available.

42.

Ameloblastoma, calcifying epithelial odontogenic tumor, and glandular odontogenic cyst show a distinctive immunophenotype with some myoepithelial antigen expression.

Gratzinger D, Salama ME, Poh CF, Rouse RV.

J Oral Pathol Med. 2008 Mar;37(3):177-84. doi: 10.1111/j.1600-0714.2007.00613.x.

PMID:
18251942
43.

Oral cancer screening in a high-risk underserved community--Vancouver Downtown Eastside.

Poh CF, Hislop G, Currie B, Lee R, Sikorski S, Zed C, Zhang L, Macaulay C, Rosin MP.

J Health Care Poor Underserved. 2007 Nov;18(4):767-78.

PMID:
17982206
44.

A magic wand for the community dental office? Observations from the British Columbia Oral Cancer Prevention Program.

Laronde DM, Poh CF, Williams PM, Hislop TG, Zhang L, MacAulay C, Rosin MP.

J Can Dent Assoc. 2007 Sep;73(7):607-9. No abstract available.

45.

Visualization and other emerging technologies as change makers for oral cancer prevention.

Rosin MP, Poh CF, Guillard M, Williams PM, Zhang L, MacaUlay C.

Ann N Y Acad Sci. 2007 Mar;1098:167-83. Epub 2007 Mar 1. Review.

PMID:
17332080
46.

Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients.

Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, Berean KW, Ng S, Tseng OL, MacAulay C, Rosin MP.

Clin Cancer Res. 2006 Nov 15;12(22):6716-22.

47.

Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device.

Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, Macaulay C, Rosin MP.

Head Neck. 2007 Jan;29(1):71-6.

PMID:
16983693
48.

Heads up! - a call for dentists to screen for oral cancer.

Poh CF, Williams PM, Zhang L, Rosin MP.

J Can Dent Assoc. 2006 Jun;72(5):413-6. No abstract available.

49.

Simple device for the direct visualization of oral-cavity tissue fluorescence.

Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, Williams PM, Zhang L, Rosin MP, MacAulay CE.

J Biomed Opt. 2006 Mar-Apr;11(2):024006.

PMID:
16674196
50.

Intramandibular inflammatory myofibroblastic tumor--a true neoplasm or reactive lesion?

Poh CF, Priddy RW, Dahlman DM.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Oct;100(4):460-6. Review.

PMID:
16182167

Supplemental Content

Support Center